A 0 1 0 1 O
positive 2 10 2 10 O
fungal 11 17 11 17 B-treatment
culture 18 25 18 25 I-treatment
within 26 32 26 32 O
30 33 35 33 35 B-upper_bound
days 36 40 36 40 I-upper_bound

Active 0 6 41 47 B-chronic_disease
fungal 7 13 48 54 I-chronic_disease
, 13 14 54 55 O
viral 15 20 56 61 B-chronic_disease
, 20 21 61 62 O
bacterial 22 31 63 72 B-chronic_disease
, 31 32 72 73 O
or 33 35 74 76 O
protozoal 36 45 77 86 B-chronic_disease
infection 46 55 87 96 I-chronic_disease
requiring 56 65 97 106 O
IV 66 68 107 109 B-treatment
treatment 69 78 110 119 I-treatment

Adequate 0 8 120 128 O
Bone 9 13 129 133 O
Marrow 14 20 134 140 O
Function 21 29 141 149 O
Defined 30 37 150 157 O
as 38 40 158 160 O
: 40 41 160 161 O
Blood 42 47 162 167 B-clinical_variable
counts 48 54 168 174 I-clinical_variable
are 55 58 175 178 O
not 59 62 179 182 O
required 63 71 183 191 O
to 72 74 192 194 O
be 75 77 195 197 O
normal 78 84 198 204 O
prior 85 90 205 210 O
to 91 93 211 213 O
enrollment 94 104 214 224 O
on 105 107 225 227 O
trial 108 113 228 233 O

Angiotensin 0 11 234 245 B-treatment
- 11 12 245 246 I-treatment
converting 12 22 246 256 I-treatment
enzyme 23 29 257 263 I-treatment
( 30 31 264 265 I-treatment
ACE 31 34 265 268 I-treatment
) 34 35 268 269 I-treatment
inhibitors 36 46 270 280 I-treatment
: 46 47 280 281 O
Patients 48 56 282 290 O
who 57 60 291 294 O
are 61 64 295 298 O
currently 65 74 299 308 O
receiving 75 84 309 318 O
ACE 85 88 319 322 B-treatment
inhibitors 89 99 323 333 I-treatment
are 100 103 334 337 O
not 104 107 338 341 O
eligible 108 116 342 350 O
due 117 120 351 354 O
to 121 123 355 357 O
the 124 127 358 361 O
development 128 139 362 373 O
of 140 142 374 376 O
angioneurotic 143 156 377 390 B-chronic_disease
edema 157 162 391 396 I-chronic_disease
- 162 163 396 397 O
type 163 167 397 401 O
reactions 168 177 402 411 O
in 178 180 412 414 O
some 181 185 415 419 O
subjects 186 194 420 428 O
who 195 198 429 432 O
received 199 207 433 441 O
concurrent 208 218 442 452 O
treatment 219 228 453 462 B-treatment
with 229 233 463 467 I-treatment
temsirolimus 234 246 468 480 I-treatment
+ 247 248 481 482 I-treatment
ACE 249 252 483 486 I-treatment
inhibitors 253 263 487 497 I-treatment

Anti 0 4 498 502 B-chronic_disease
- 4 5 502 503 I-chronic_disease
GVHD 5 9 503 507 I-chronic_disease
or 10 12 508 510 O
agents 13 19 511 517 O
to 20 22 518 520 O
prevent 23 30 521 528 O
organ 31 36 529 534 B-treatment
rejection 37 46 535 544 I-treatment
post 47 51 545 549 I-treatment
- 51 52 549 550 I-treatment
transplant 52 62 550 560 I-treatment
: 62 63 560 561 O
Patients 64 72 562 570 O
who 73 76 571 574 O
are 77 80 575 578 O
receiving 81 90 579 588 O
cyclosporine 91 103 589 601 B-treatment
, 103 104 601 602 O
tacrolimus 105 115 603 613 B-treatment
or 116 118 614 616 O
other 119 124 617 622 O
agents 125 131 623 629 O
to 132 134 630 632 O
prevent 135 142 633 640 O
either 143 149 641 647 O
graft 150 155 648 653 B-chronic_disease
- 155 156 653 654 I-chronic_disease
versus 156 162 654 660 I-chronic_disease
- 162 163 660 661 I-chronic_disease
host 163 167 661 665 I-chronic_disease
disease 168 175 666 673 I-chronic_disease
post 176 180 674 678 B-treatment
bone 181 185 679 683 I-treatment
marrow 186 192 684 690 I-treatment
transplant 193 203 691 701 I-treatment
or 204 206 702 704 O
organ 207 212 705 710 B-treatment
rejection 213 222 711 720 I-treatment
post 223 227 721 725 I-treatment
transplant 228 238 726 736 I-treatment
are 239 242 737 740 O
not 243 246 741 744 O
eligible 247 255 745 753 O
for 256 259 754 757 O
this 260 264 758 762 O
trial 265 270 763 768 O

Anti 0 4 769 773 B-treatment
- 4 5 773 774 I-treatment
cancer 5 11 774 780 I-treatment
Agents 12 18 781 787 I-treatment
: 18 19 787 788 O
Patients 20 28 789 797 O
who 29 32 798 801 O
are 33 36 802 805 O
currently 37 46 806 815 O
receiving 47 56 816 825 O
or 57 59 826 828 O
may 60 63 829 832 O
receive 64 71 833 840 O
while 72 77 841 846 O
on 78 80 847 849 O
therapy 81 88 850 857 B-treatment
, 88 89 857 858 O
other 90 95 859 864 O
anti 96 100 865 869 B-treatment
- 100 101 869 870 I-treatment
cancer 101 107 870 876 I-treatment
agents 108 114 877 883 I-treatment
, 114 115 883 884 O
radiation 116 125 885 894 B-treatment
therapy 126 133 895 902 I-treatment
or 134 136 903 905 O
immunotherapy 137 150 906 919 B-treatment
are 151 154 920 923 O
not 155 158 924 927 O
eligible 159 167 928 936 O

Anticoagulants 0 14 937 951 B-treatment
: 14 15 951 952 O
Patients 16 24 953 961 O
who 25 28 962 965 O
are 29 32 966 969 O
currently 33 42 970 979 O
receiving 43 52 980 989 O
therapeutic 53 64 990 1001 B-treatment
anticoagulants 65 79 1002 1016 I-treatment
( 80 81 1017 1018 O
including 81 90 1018 1027 O
aspirin 91 98 1028 1035 B-treatment
, 98 99 1035 1036 O
low 100 103 1037 1040 B-treatment
molecular 104 113 1041 1050 I-treatment
weight 114 120 1051 1057 I-treatment
heparin 121 128 1058 1065 I-treatment
, 128 129 1065 1066 O
and 130 133 1067 1070 O
others 134 140 1071 1077 O
) 140 141 1077 1078 O
are 142 145 1079 1082 O
not 146 149 1083 1086 O
eligible 150 158 1087 1095 O

At 0 2 1096 1098 O
least 3 8 1099 1104 O
14 9 11 1105 1107 B-lower_bound
days 12 16 1108 1112 I-lower_bound
must 17 21 1113 1117 O
have 22 26 1118 1122 O
elapsed 27 34 1123 1130 O
after 35 40 1131 1136 O
the 41 44 1137 1140 O
completion 45 55 1141 1151 O
of 56 58 1152 1154 O
cytotoxic 59 68 1155 1164 B-treatment
therapy 69 76 1165 1172 I-treatment
, 76 77 1172 1173 O
with 78 82 1174 1178 O
the 83 86 1179 1182 O
exception 87 96 1183 1192 O
of 97 99 1193 1195 O
hydroxyurea 100 111 1196 1207 B-treatment

At 0 2 1208 1210 O
least 3 8 1211 1216 O
3 9 10 1217 1218 B-lower_bound
half 11 15 1219 1223 I-lower_bound
- 15 16 1223 1224 I-lower_bound
lives 16 21 1224 1229 I-lower_bound
must 22 26 1230 1234 O
have 27 31 1235 1239 O
elapsed 32 39 1240 1247 O
after 40 45 1248 1253 O
the 46 49 1254 1257 O
last 50 54 1258 1262 O
dose 55 59 1263 1267 O
of 60 62 1268 1270 O
GVHD 63 67 1271 1275 B-treatment
meds 68 72 1276 1280 I-treatment

At 0 2 1281 1283 O
least 3 8 1284 1289 O
42 9 11 1290 1292 B-lower_bound
days 12 16 1293 1297 I-lower_bound
must 17 21 1298 1302 O
have 22 26 1303 1307 O
elapsed 27 34 1308 1315 O
if 35 37 1316 1318 O
other 38 43 1319 1324 O
substantial 44 55 1325 1336 O
marrow 56 62 1337 1343 B-treatment
radiation 63 72 1344 1353 I-treatment

At 0 2 1354 1356 O
least 3 8 1357 1362 O
84 9 11 1363 1365 B-lower_bound
days 12 16 1366 1370 I-lower_bound
must 17 21 1371 1375 O
have 22 26 1376 1380 O
elapsed 27 34 1381 1388 O
if 35 37 1389 1391 O
prior 38 43 1392 1397 O
TBI 44 47 1398 1401 B-chronic_disease
, 47 48 1401 1402 O
craniospinal 49 61 1403 1415 B-treatment
XRT 62 65 1416 1419 I-treatment
or 66 68 1420 1422 O
if 69 71 1423 1425 O
greater 72 79 1426 1433 O
than 80 84 1434 1438 O
or 85 87 1439 1441 O
equal 88 93 1442 1447 O
to 94 96 1448 1450 O
50 97 99 1451 1453 B-lower_bound
% 99 100 1453 1454 I-lower_bound
radiation 101 110 1455 1464 O
of 111 113 1465 1467 O
pelvis 114 120 1468 1474 O

Baseline 0 8 1475 1483 O
chest 9 14 1484 1489 O
x 15 16 1490 1491 O
- 16 17 1491 1492 O
ray 17 20 1492 1495 O
with 21 25 1496 1500 O
no 26 28 1501 1503 O
evidence 29 37 1504 1512 O
of 38 40 1513 1515 O
active 41 47 1516 1522 O
infectious 48 58 1523 1533 B-chronic_disease
disease 59 66 1534 1541 I-chronic_disease
or 67 69 1542 1544 O
pneumonitis 70 81 1545 1556 B-chronic_disease

Biologic 0 8 1557 1565 B-treatment
( 9 10 1566 1567 O
anti 10 14 1567 1571 B-treatment
- 14 15 1571 1572 I-treatment
neoplastic 15 25 1572 1582 I-treatment
agent 26 31 1583 1588 I-treatment
): 31 33 1588 1590 O
At 34 36 1591 1593 O
least 37 42 1594 1599 O
7 43 44 1600 1601 B-lower_bound
days 45 49 1602 1606 I-lower_bound
after 50 55 1607 1612 I-lower_bound
the 56 59 1613 1616 O
last 60 64 1617 1621 O
dose 65 69 1622 1626 O
of 70 72 1627 1629 O
a 73 74 1630 1631 O
biologic 75 83 1632 1640 B-treatment
agent 84 89 1641 1646 I-treatment

Bone 0 4 1647 1651 O
marrow 5 11 1652 1658 O
involvement 12 23 1659 1670 O
defined 24 31 1671 1678 O
as 32 34 1679 1681 O
ALL 35 38 1682 1685 B-cancer
â‰¥ 39 40 1686 1687 O
25 41 43 1688 1690 B-lower_bound
% 43 44 1690 1691 I-lower_bound
blasts 45 51 1692 1698 O
( 52 53 1699 1700 O
M2 53 55 1700 1702 O
or 56 58 1703 1705 O
M3 59 61 1706 1708 O
) 61 62 1708 1709 O
with 63 67 1710 1714 O
or 68 70 1715 1717 O
without 71 78 1718 1725 O
extramedullary 79 93 1726 1740 O
involvement 94 105 1741 1752 O

Calcium 0 7 1753 1760 B-treatment
Channel 8 15 1761 1768 I-treatment
Blockers 16 24 1769 1777 I-treatment
: 24 25 1777 1778 O
Patients 26 34 1779 1787 O
who 35 38 1788 1791 O
are 39 42 1792 1795 O
currently 43 52 1796 1805 O
receiving 53 62 1806 1815 O
Calcium 63 70 1816 1823 O
Channel 71 78 1824 1831 O
Blockers 79 87 1832 1840 O
are 88 91 1841 1844 O
not 92 95 1845 1848 O
eligible 96 104 1849 1857 O
due 105 108 1858 1861 O
to 109 111 1862 1864 O
the 112 115 1865 1868 O
development 116 127 1869 1880 O
of 128 130 1881 1883 O
angioneurotic 131 144 1884 1897 B-chronic_disease
edema 145 150 1898 1903 I-chronic_disease
- 150 151 1903 1904 O
type 151 155 1904 1908 O
reactions 156 165 1909 1918 O
in 166 168 1919 1921 O
some 169 173 1922 1926 O
subjects 174 182 1927 1935 O
who 183 186 1936 1939 O
received 187 195 1940 1948 O
concurrent 196 206 1949 1959 O
treatment 207 216 1960 1969 B-treatment
with 217 221 1970 1974 I-treatment
temsirolimus 222 234 1975 1987 I-treatment
+ 235 236 1988 1989 I-treatment
Calcium 237 244 1990 1997 I-treatment
Channel 245 252 1998 2005 I-treatment
Blockers 253 261 2006 2014 I-treatment

Corticosteroids 0 15 2015 2030 B-treatment
: 15 16 2030 2031 O
Patients 17 25 2032 2040 O
receiving 26 35 2041 2050 O
corticosteroids 36 51 2051 2066 B-treatment
who 52 55 2067 2070 O
have 56 60 2071 2075 O
not 61 64 2076 2079 O
been 65 69 2080 2084 O
on 70 72 2085 2087 O
a 73 74 2088 2089 O
stable 75 81 2090 2096 O
or 82 84 2097 2099 O
decreasing 85 95 2100 2110 O
dose 96 100 2111 2115 O
of 101 103 2116 2118 O
corticosteroid 104 118 2119 2133 O
for 119 122 2134 2137 O
at 123 125 2138 2140 O
least 126 131 2141 2146 O
7 132 133 2147 2148 B-lower_bound
days 134 138 2149 2153 I-lower_bound
prior 139 144 2154 2159 I-lower_bound
to 145 147 2160 2162 O
enrollment 148 158 2163 2173 O
are 159 162 2174 2177 O
not 163 166 2178 2181 O
eligible 167 175 2182 2190 O

Creatinine 0 10 2191 2201 B-clinical_variable
clearance 11 20 2202 2211 I-clinical_variable
or 21 23 2212 2214 O
radioisotope 24 36 2215 2227 B-clinical_variable
GFR 37 40 2228 2231 I-clinical_variable
greater 41 48 2232 2239 O
than 49 53 2240 2244 O
or 54 56 2245 2247 O
equal 57 62 2248 2253 O
to 63 65 2254 2256 O
70ml 66 70 2257 2261 B-lower_bound
/ 70 71 2261 2262 I-lower_bound
min/1.73 71 79 2262 2270 I-lower_bound
m2 80 82 2271 2273 I-lower_bound

Ejection 0 8 2274 2282 B-clinical_variable
fraction 9 17 2283 2291 I-clinical_variable
of 18 20 2292 2294 O
â‰¥ 21 22 2295 2296 O
50 23 25 2297 2299 B-lower_bound
% 25 26 2299 2300 I-lower_bound
by 27 29 2301 2303 O
gated 30 35 2304 2309 O
radionuclide 36 48 2310 2322 O
study 49 54 2323 2328 O

Enzyme 0 6 2329 2335 B-treatment
inducing 7 15 2336 2344 I-treatment
Anti 16 20 2345 2349 I-treatment
- 20 21 2349 2350 I-treatment
convulsants 21 32 2350 2361 I-treatment
: 32 33 2361 2362 O
Patients 34 42 2363 2371 O
who 43 46 2372 2375 O
are 47 50 2376 2379 O
currently 51 60 2380 2389 O
receiving 61 70 2390 2399 O
enzyme 71 77 2400 2406 B-treatment
inducing 78 86 2407 2415 I-treatment
anticonvulsants 87 102 2416 2431 I-treatment
( 103 104 2432 2433 O
ie 104 106 2433 2435 O
phenytoin 107 116 2436 2445 B-treatment
, 116 117 2445 2446 O
phenobarbitol 118 131 2447 2460 B-treatment
, 131 132 2460 2461 O
or 133 135 2462 2464 O
carbamazepine 136 149 2465 2478 B-treatment
) 149 150 2478 2479 O
are 151 154 2480 2483 O
not 155 158 2484 2487 O
eligible 159 167 2488 2496 O

Fasting 0 7 2497 2504 O
or 8 10 2505 2507 O
non 11 14 2508 2511 B-clinical_variable
- 14 15 2511 2512 I-clinical_variable
fasting 15 22 2512 2519 I-clinical_variable
serum 23 28 2520 2525 I-clinical_variable
triglyceride 29 41 2526 2538 I-clinical_variable
level 42 47 2539 2544 I-clinical_variable
â‰¤ 48 49 2545 2546 O
300 50 53 2547 2550 B-upper_bound
mg 54 56 2551 2553 I-upper_bound
/ 56 57 2553 2554 I-upper_bound
dL 57 59 2554 2556 I-upper_bound
and 60 63 2557 2560 O
serum 64 69 2561 2566 B-clinical_variable
cholesterol 70 81 2567 2578 I-clinical_variable
level 82 87 2579 2584 I-clinical_variable
â‰¤ 88 89 2585 2586 O
300 90 93 2587 2590 O
mg 94 96 2591 2593 O
/ 96 97 2593 2594 O
dL 97 99 2594 2596 O

Female 0 6 2597 2603 B-gender
patients 7 15 2604 2612 I-gender
of 16 18 2613 2615 O
childbearing 19 31 2616 2628 O
potential 32 41 2629 2638 O
must 42 46 2639 2643 O
have 47 51 2644 2648 O
a 52 53 2649 2650 O
negative 54 62 2651 2659 B-pregnancy
urine 63 68 2660 2665 I-pregnancy
or 69 71 2666 2668 I-pregnancy
serum 72 77 2669 2674 I-pregnancy
pregnancy 78 87 2675 2684 I-pregnancy
test 88 92 2685 2689 O
confirmed 93 102 2690 2699 O
prior 103 108 2700 2705 O
to 109 111 2706 2708 O
enrollment 112 122 2709 2719 O

Female 0 6 2720 2726 B-gender
patients 7 15 2727 2735 I-gender
with 16 20 2736 2740 O
infants 21 28 2741 2748 O
must 29 33 2749 2753 O
agree 34 39 2754 2759 O
not 40 43 2760 2763 O
to 44 46 2764 2766 O
breastfeed 47 57 2767 2777 O
their 58 63 2778 2783 O
infants 64 71 2784 2791 O
while 72 77 2792 2797 O
on 78 80 2798 2800 O
this 81 85 2801 2805 O
study 86 91 2806 2811 O

Fever 0 5 2812 2817 B-clinical_variable
above 6 11 2818 2823 O
38.2 12 16 2824 2828 B-lower_bound
within 17 23 2829 2835 O
48 24 26 2836 2838 B-upper_bound
hours 27 32 2839 2844 I-upper_bound
of 33 35 2845 2847 O
study 36 41 2848 2853 O
enrollment 42 52 2854 2864 O
with 53 57 2865 2869 O
clinical 58 66 2870 2878 O
signs 67 72 2879 2884 O
of 73 75 2885 2887 O
infection 76 85 2888 2897 B-chronic_disease

First 0 5 2898 2903 O
or 6 8 2904 2906 O
greater 9 16 2907 2914 O
relapse 17 24 2915 2922 O
T 25 26 2923 2924 B-cancer
- 26 27 2924 2925 I-cancer
cell 27 31 2925 2929 I-cancer
ALL 32 35 2930 2933 I-cancer
patients 36 44 2934 2942 O
are 45 48 2943 2946 O
eligible 49 57 2947 2955 O
at 58 60 2956 2958 O
time 61 65 2959 2963 O
of 66 68 2964 2966 O
relapse 69 76 2967 2974 O
or 77 79 2975 2977 O
with 80 84 2978 2982 O
refractory 85 95 2983 2993 B-chronic_disease
disease 96 103 2994 3001 I-chronic_disease

First 0 5 3002 3007 O
relapse 6 13 3008 3015 O
B 14 15 3016 3017 B-cancer
- 15 16 3017 3018 I-cancer
cell 16 20 3018 3022 I-cancer
ALL 21 24 3023 3026 I-cancer
patients 25 33 3027 3035 O
are 34 37 3036 3039 O
eligible 38 46 3040 3048 O
with 47 51 3049 3053 O
refractory 52 62 3054 3064 B-chronic_disease
disease 63 70 3065 3072 I-chronic_disease

GGT 0 3 3073 3076 B-clinical_variable
must 4 8 3077 3081 O
be 9 11 3082 3084 O
less 12 16 3085 3089 O
than 17 21 3090 3094 O
2.5 22 25 3095 3098 B-upper_bound
x 26 27 3099 3100 I-upper_bound
institutional 28 41 3101 3114 I-upper_bound
upper 42 47 3115 3120 I-upper_bound
limit 48 53 3121 3126 I-upper_bound
of 54 56 3127 3129 I-upper_bound
normal 57 63 3130 3136 I-upper_bound

Grade 0 5 3137 3142 B-upper_bound
1 6 7 3143 3144 I-upper_bound
or 8 10 3145 3147 O
less 11 15 3148 3152 O
per 16 19 3153 3156 O
CTCAE 20 25 3157 3162 B-clinical_variable
4 26 27 3163 3164 I-clinical_variable

Hematopoietic 0 13 3165 3178 B-treatment
growth 14 20 3179 3185 I-treatment
factors 21 28 3186 3193 I-treatment
: 28 29 3193 3194 O
At 30 32 3195 3197 O
least 33 38 3198 3203 O
14 39 41 3204 3206 B-lower_bound
days 42 46 3207 3211 I-lower_bound
after 47 52 3212 3217 O
the 53 56 3218 3221 O
last 57 61 3222 3226 O
dose 62 66 3227 3231 O
of 67 69 3232 3234 O
a 70 71 3235 3236 O
long 72 76 3237 3241 B-treatment
- 76 77 3241 3242 I-treatment
acting 77 83 3242 3248 I-treatment
growth 84 90 3249 3255 I-treatment
factor 91 97 3256 3262 I-treatment
( 98 99 3263 3264 O
e.g. 99 103 3264 3268 O
Neulasta 104 112 3269 3277 B-treatment
) 112 113 3277 3278 O
or 114 116 3279 3281 O
7 117 118 3282 3283 B-lower_bound
days 119 123 3284 3288 I-lower_bound
for 124 127 3289 3292 O
short 128 133 3293 3298 B-treatment
- 133 134 3298 3299 I-treatment
acting 134 140 3299 3305 I-treatment
growth 141 147 3306 3312 I-treatment
factor 148 154 3313 3319 I-treatment

If 0 2 3320 3322 O
the 3 6 3323 3326 O
initial 7 14 3327 3334 O
blood 15 20 3335 3340 B-clinical_variable
glucose 21 28 3341 3348 I-clinical_variable
is 29 31 3349 3351 O
non 32 35 3352 3355 O
- 35 36 3355 3356 O
fasting 36 43 3356 3363 O
and 44 47 3364 3367 O
above 48 53 3368 3373 O
normal 54 60 3374 3380 O
limits 61 67 3381 3387 O
a 68 69 3388 3389 O
fasting 70 77 3390 3397 B-clinical_variable
glucose 78 85 3398 3405 I-clinical_variable
can 86 89 3406 3409 O
be 90 92 3410 3412 O
obtained 93 101 3413 3421 O
and 102 105 3422 3425 O
must 106 110 3426 3430 O
be 111 113 3431 3433 O
within 114 120 3434 3440 O
the 121 124 3441 3444 O
upper 125 130 3445 3450 O
limits 131 137 3451 3457 O
of 138 140 3458 3460 O
normal 141 147 3461 3467 O
for 148 151 3468 3471 O
age 152 155 3472 3475 B-age

Immunotherapy 0 13 3476 3489 B-treatment
: 13 14 3489 3490 O
At 15 17 3491 3493 O
least 18 23 3494 3499 O
30 24 26 3500 3502 B-lower_bound
days 27 31 3503 3507 I-lower_bound
after 32 37 3508 3513 O
the 38 41 3514 3517 O
completion 42 52 3518 3528 O
of 53 55 3529 3531 O
any 56 59 3532 3535 O
type 60 64 3536 3540 O
of 65 67 3541 3543 O
immunotherapy 68 81 3544 3557 B-treatment
, 81 82 3557 3558 O
e.g. 83 87 3559 3563 O
tumor 88 93 3564 3569 B-treatment
vaccines 94 102 3570 3578 I-treatment
. 102 103 3578 3579 O
or 104 106 3580 3582 O
chimeric 107 115 3583 3591 B-treatment
antigen 116 123 3592 3599 I-treatment
receptor 124 132 3600 3608 I-treatment
T 133 134 3609 3610 I-treatment
cell 135 139 3611 3615 I-treatment
( 140 141 3616 3617 I-treatment
CART 141 145 3617 3621 I-treatment
) 145 146 3621 3622 I-treatment
therapy 147 154 3623 3630 I-treatment
or 155 157 3631 3633 O
tumor 158 163 3634 3639 O
vaccines 164 172 3640 3648 O

Investigational 0 15 3649 3664 B-treatment
Drugs 16 21 3665 3670 I-treatment
: 21 22 3670 3671 O
Patients 23 31 3672 3680 O
who 32 35 3681 3684 O
are 36 39 3685 3688 O
currently 40 49 3689 3698 O
receiving 50 59 3699 3708 O
another 60 67 3709 3716 O
investigational 68 83 3717 3732 B-treatment
drug 84 88 3733 3737 I-treatment
are 89 92 3738 3741 O
not 93 96 3742 3745 O
eligible 97 105 3746 3754 O

Isolated 0 8 3755 3763 O
CNS 9 12 3764 3767 O
2 13 14 3768 3769 B-lower_bound
or 15 17 3770 3772 O
3 18 19 3773 3774 B-upper_bound
patients 20 28 3775 3783 B-clinical_variable
with 29 33 3784 3788 O
< 34 35 3789 3790 O
0.1 36 39 3791 3794 B-upper_bound
% 39 40 3794 3795 I-upper_bound
MRD 41 44 3796 3799 O
bone 45 49 3800 3804 O
marrow 50 56 3805 3811 O
involvement 57 68 3812 3823 O
are 69 72 3824 3827 O
not 73 76 3828 3831 O
eligible 77 85 3832 3840 O

Karnofsky 0 9 3841 3850 B-clinical_variable
greater 10 17 3851 3858 O
than 18 22 3859 3863 O
or 23 25 3864 3866 O
equal 26 31 3867 3872 O
to 32 34 3873 3875 O
50 35 37 3876 3878 B-lower_bound
% 37 38 3878 3879 I-lower_bound
for 39 42 3880 3883 O
patients 43 51 3884 3892 O
> 52 53 3893 3894 O
16 54 56 3895 3897 O
years 57 62 3898 3903 O
of 63 65 3904 3906 O
age 66 69 3907 3910 B-age
and 70 73 3911 3914 O
Lansky 74 80 3915 3921 B-clinical_variable
greater 81 88 3922 3929 O
than 89 93 3930 3934 O
or 94 96 3935 3937 O
equal 97 102 3938 3943 O
to 103 105 3944 3946 O
50 106 108 3947 3949 O
for 109 112 3950 3953 O
patients 113 121 3954 3962 O
â‰¤ 122 123 3963 3964 O
16 124 126 3965 3967 O
years 127 132 3968 3973 O
of 133 135 3974 3976 O
age 136 139 3977 3980 O

Leukemia 0 8 3981 3989 B-cancer

Lymphoma 0 8 3990 3998 B-cancer

Male 0 4 3999 4003 B-gender
and 5 8 4004 4007 I-gender
female 9 15 4008 4014 I-gender
patients 16 24 4015 4023 I-gender
of 25 27 4024 4026 O
child 28 33 4027 4032 O
- 33 34 4032 4033 O
bearing 34 41 4033 4040 O
potential 42 51 4041 4050 O
must 52 56 4051 4055 O
agree 57 62 4056 4061 B-contraception_consent
to 63 65 4062 4064 I-contraception_consent
use 66 69 4065 4068 I-contraception_consent
an 70 72 4069 4071 I-contraception_consent
effective 73 82 4072 4081 I-contraception_consent
method 83 89 4082 4088 I-contraception_consent
of 90 92 4089 4091 I-contraception_consent
contraception 93 106 4092 4105 I-contraception_consent
approved 107 115 4106 4114 O
by 116 118 4115 4117 O
the 119 122 4118 4121 O
investigator 123 135 4122 4134 O
during 136 142 4135 4141 O
the 143 146 4142 4145 O
study 147 152 4146 4151 O

Monoclonal 0 10 4152 4162 B-treatment
antibodies 11 21 4163 4173 I-treatment
: 21 22 4173 4174 O
At 23 25 4175 4177 O
least 26 31 4178 4183 O
3 32 33 4184 4185 B-lower_bound
half 34 38 4186 4190 O
- 38 39 4190 4191 O
lives 39 44 4191 4196 O
of 45 47 4197 4199 O
the 48 51 4200 4203 O
antibody 52 60 4204 4212 O
must 61 65 4213 4217 O
have 66 70 4218 4222 O
elapsed 71 78 4223 4230 O
after 79 84 4231 4236 O
the 85 88 4237 4240 O
last 89 93 4241 4245 O
dose 94 98 4246 4250 O
of 99 101 4251 4253 O
a 102 103 4254 4255 O
monoclonal 104 114 4256 4266 B-treatment
antibody 115 123 4267 4275 I-treatment

Newly 0 5 4276 4281 O
diagnosed 6 15 4282 4291 O
patients 16 24 4292 4300 O
( 25 26 4301 4302 O
T 26 27 4302 4303 B-cancer
or 28 30 4304 4306 I-cancer
B 31 32 4307 4308 I-cancer
- 32 33 4308 4309 I-cancer
cell 33 37 4309 4313 I-cancer
ALL 38 41 4314 4317 I-cancer
) 41 42 4317 4318 O
with 43 47 4319 4323 O
refractory 48 58 4324 4334 O
bone 59 63 4335 4339 O
marrow 64 70 4340 4346 O
involvement 71 82 4347 4358 O
after 83 88 4359 4364 O
Consolidation 89 102 4365 4378 B-treatment
therapy 103 110 4379 4386 I-treatment
are 111 114 4387 4390 O
eligible 115 123 4391 4399 O

No 0 2 4400 4402 O
evidence 3 11 4403 4411 O
of 12 14 4412 4414 O
dyspnea 15 22 4415 4422 B-chronic_disease
at 23 25 4423 4425 O
rest 26 30 4426 4430 O
and 31 34 4431 4434 O
no 35 37 4435 4437 O
exercise 38 46 4438 4446 O
intolerance 47 58 4447 4458 O

Normal 0 6 4459 4465 O
serum 7 12 4466 4471 O
creatinine 13 23 4472 4482 B-clinical_variable
based 24 29 4483 4488 O
on 30 32 4489 4491 O
age 33 36 4492 4495 B-age
and 37 40 4496 4499 O
gender 41 47 4500 4506 O

Patient 0 7 4507 4514 O
must 8 12 4515 4519 O
have 13 17 4520 4524 O
evaluable 18 27 4525 4534 O
or 28 30 4535 4537 O
measurable 31 41 4538 4548 O
disease 42 49 4549 4556 O
documented 50 60 4557 4567 O
by 61 63 4568 4570 O
clinical 64 72 4571 4579 O
or 73 75 4580 4582 O
radiographic 76 88 4583 4595 O
criteria 89 97 4596 4604 O
or 98 100 4605 4607 O
bone 101 105 4608 4612 B-chronic_disease
marrow 106 112 4613 4619 I-chronic_disease
disease 113 120 4620 4627 I-chronic_disease
present 121 128 4628 4635 O
at 129 131 4636 4638 O
study 132 137 4639 4644 O
entr 138 142 4645 4649 O

Patient 0 7 4650 4657 O
must 8 12 4658 4662 O
have 13 17 4663 4667 O
relapsed 18 26 4668 4676 O
or 27 29 4677 4679 O
refractory 30 40 4680 4690 O
lymphoblastic 41 54 4691 4704 B-cancer
lymphoma 55 63 4705 4713 I-cancer
or 64 66 4714 4716 O
peripheral 67 77 4717 4727 B-cancer
T 78 79 4728 4729 I-cancer
- 79 80 4729 4730 I-cancer
cell 80 84 4730 4734 I-cancer
lymphoma 85 93 4735 4743 I-cancer

Patient 0 7 4744 4751 O
with 8 12 4752 4756 O
Burkiett 13 21 4757 4765 B-cancer
's 21 23 4765 4767 I-cancer
leukemia 24 32 4768 4776 I-cancer
and 33 36 4777 4780 O
/or 37 40 4781 4784 O
lymphoma 41 49 4785 4793 B-cancer
are 50 53 4794 4797 O
not 54 57 4798 4801 O
eligible 58 66 4802 4810 O

Patients 0 8 4811 4819 O
may 9 12 4820 4823 O
have 13 17 4824 4828 O
CNS 18 21 4829 4832 B-chronic_disease
2 22 23 4833 4834 I-chronic_disease
or 24 26 4835 4837 I-chronic_disease
3 27 28 4838 4839 I-chronic_disease
disease 29 36 4840 4847 I-chronic_disease

Patients 0 8 4848 4856 O
must 9 13 4857 4861 O
be 14 16 4862 4864 O
greater 17 24 4865 4872 O
than 25 29 4873 4877 O
or 30 32 4878 4880 O
equal 33 38 4881 4886 O
to 39 41 4887 4889 O
12 42 44 4890 4892 B-lower_bound
months 45 51 4893 4899 I-lower_bound
and 52 55 4900 4903 O
â‰¤ 56 57 4904 4905 O
21 58 60 4906 4908 B-upper_bound
years 61 66 4909 4914 I-upper_bound
of 67 69 4915 4917 O
age 70 73 4918 4921 B-age
at 74 76 4922 4924 O
the 77 80 4925 4928 O
time 81 85 4929 4933 O
of 86 88 4934 4936 O
study 89 94 4937 4942 O
enrollment 95 105 4943 4953 O

Patients 0 8 4954 4962 O
must 9 13 4963 4967 O
have 14 18 4968 4972 O
been 19 23 4973 4977 O
off 24 27 4978 4981 O
blinatumomab 28 40 4982 4994 B-treatment
infusion 41 49 4995 5003 I-treatment
for 50 53 5004 5007 O
at 54 56 5008 5010 O
least 57 62 5011 5016 O
4 63 64 5017 5018 B-lower_bound
days 65 69 5019 5023 I-lower_bound
and 70 73 5024 5027 O
all 74 77 5028 5031 O
drug 78 82 5032 5036 O
- 82 83 5036 5037 O
related 83 90 5037 5044 O
toxicity 91 99 5045 5053 O
must 100 104 5054 5058 O
have 105 109 5059 5063 O
resolved 110 118 5064 5072 O
to 119 121 5073 5075 O
grade 122 127 5076 5081 B-upper_bound
2 128 129 5082 5083 I-upper_bound
or 130 132 5084 5086 O
lower 133 138 5087 5092 O
as 139 141 5093 5095 O
outlined 142 150 5096 5104 O
in 151 153 5105 5107 O
the 154 157 5108 5111 O
inclusion 158 167 5112 5121 O
and 168 171 5122 5125 O
exclusion 172 181 5126 5135 O
criteria 182 190 5136 5144 O

Patients 0 8 5145 5153 O
must 9 13 5154 5158 O
have 14 18 5159 5163 O
fully 19 24 5164 5169 O
recovered 25 34 5170 5179 O
from 35 39 5180 5184 O
the 40 43 5185 5188 O
acute 44 49 5189 5194 O
toxic 50 55 5195 5200 O
effects 56 63 5201 5208 O
of 64 66 5209 5211 O
all 67 70 5212 5215 O
prior 71 76 5216 5221 B-treatment
anti 77 81 5222 5226 I-treatment
- 81 82 5226 5227 I-treatment
cancer 82 88 5227 5233 I-treatment
chemotherapy 89 101 5234 5246 I-treatment

Patients 0 8 5247 5255 O
presenting 9 19 5256 5266 O
with 20 24 5267 5271 O
visual 25 31 5272 5278 O
disturbances 32 44 5279 5291 O
by 45 47 5292 5294 O
history 48 55 5295 5302 O
or 56 58 5303 5305 O
physical 59 67 5306 5314 O
exam 68 72 5315 5319 O
should 73 79 5320 5326 O
have 80 84 5327 5331 O
an 85 87 5332 5334 O
ophthalmological 88 104 5335 5351 O
exam 105 109 5352 5356 O
and 110 113 5357 5360 O
, 113 114 5360 5361 O
if 115 117 5362 5364 O
indicated 118 127 5365 5374 O
, 127 128 5374 5375 O
an 129 131 5376 5378 O
MRI 132 135 5379 5382 B-treatment
to 136 138 5383 5385 O
determine 139 148 5386 5395 O
optic 149 154 5396 5401 O
nerve 155 160 5402 5407 O
or 161 163 5408 5410 O
retinal 164 171 5411 5418 O
involvement 172 183 5419 5430 O

Patients 0 8 5431 5439 O
receiving 9 18 5440 5449 O
treatment 19 28 5450 5459 B-treatment
with 29 33 5460 5464 O
azoles 34 40 5465 5471 B-treatment
such 41 45 5472 5476 O
as 46 48 5477 5479 O
fluconazole 49 60 5480 5491 B-treatment
or 61 63 5492 5494 O
voriconazole 64 76 5495 5507 B-treatment
which 77 82 5508 5513 O
are 83 86 5514 5517 O
potent 87 93 5518 5524 O
inhibitors 94 104 5525 5535 O
of 105 107 5536 5538 O
temsirolimus 108 120 5539 5551 O
metabolism 121 131 5552 5562 O

Patients 0 8 5563 5571 O
should 9 15 5572 5578 O
not 16 19 5579 5582 O
be 20 22 5583 5585 O
known 23 28 5586 5591 O
to 29 31 5592 5594 O
be 32 34 5595 5597 O
refractory 35 45 5598 5608 B-treatment
to 46 48 5609 5611 I-treatment
red 49 52 5612 5615 I-treatment
blood 53 58 5616 5621 I-treatment
cell 59 63 5622 5626 I-treatment
or 64 66 5627 5629 O
platelet 67 75 5630 5638 B-treatment
transfusions 76 88 5639 5651 I-treatment

Patients 0 8 5652 5660 O
will 9 13 5661 5665 O
be 14 16 5666 5668 O
excluded 17 25 5669 5677 O
if 26 28 5678 5680 O
they 29 33 5681 5685 O
have 34 38 5686 5690 O
significant 39 50 5691 5702 O
concurrent 51 61 5703 5713 O
disease 62 69 5714 5721 O
, 69 70 5721 5722 O
illness 71 78 5723 5730 O
, 78 79 5730 5731 O
psychiatric 80 91 5732 5743 B-chronic_disease
disorder 92 100 5744 5752 I-chronic_disease
or 101 103 5753 5755 O
social 104 110 5756 5762 O
issue 111 116 5763 5768 O
that 117 121 5769 5773 O
would 122 127 5774 5779 O
compromise 128 138 5780 5790 O
patient 139 146 5791 5798 O
safety 147 153 5799 5805 O
or 154 156 5806 5808 O
compliance 157 167 5809 5819 O
with 168 172 5820 5824 O
protocol 173 181 5825 5833 B-treatment
treatment 182 191 5834 5843 I-treatment
or 192 194 5844 5846 O
required 195 203 5847 5855 O
observations 204 216 5856 5868 O
, 216 217 5868 5869 O
interfere 218 227 5870 5879 O
with 228 232 5880 5884 O
consent 233 240 5885 5892 O
, 240 241 5892 5893 O
study 242 247 5894 5899 O
participation 248 261 5900 5913 O
, 261 262 5913 5914 O
follow 263 269 5915 5921 O
up 270 272 5922 5924 O
, 272 273 5924 5925 O
or 274 276 5926 5928 O
interpretation 277 291 5929 5943 O
of 292 294 5944 5946 O
study 295 300 5947 5952 O
results 301 308 5953 5960 O

Patients 0 8 5961 5969 O
with 9 13 5970 5974 O
Down 14 18 5975 5979 B-chronic_disease
syndrome 19 27 5980 5988 I-chronic_disease
and 28 31 5989 5992 O
Fanconi 32 39 5993 6000 B-chronic_disease
Anemia 40 46 6001 6007 I-chronic_disease

Patients 0 8 6008 6016 O
with 9 13 6017 6021 O
known 14 19 6022 6027 O
optic 20 25 6028 6033 O
nerve 26 31 6034 6039 O
and/or 32 38 6040 6046 O
retinal 39 46 6047 6054 O
involvement 47 58 6055 6066 O
( 59 60 6067 6068 O
because 60 67 6068 6075 O
it 68 70 6076 6078 O
may 71 74 6079 6082 O
not 75 78 6083 6086 O
be 79 81 6087 6089 O
possible 82 90 6090 6098 O
to 91 93 6099 6101 O
safely 94 100 6102 6108 O
delay 101 106 6109 6114 O
irradiation 107 118 6115 6126 B-treatment
) 118 119 6126 6127 O
are 120 123 6128 6131 O
not 124 127 6132 6135 O
eligible 128 136 6136 6144 O

Patients 0 8 6145 6153 O
with 9 13 6154 6158 O
leukemia 14 22 6159 6167 B-cancer
or 23 25 6168 6170 O
lymphoma 26 34 6171 6179 B-cancer
who 35 38 6180 6183 O
relapse 39 46 6184 6191 O
while 47 52 6192 6197 O
receiving 53 62 6198 6207 O
maintenance 63 74 6208 6219 O
chemotherapy 75 87 6220 6232 B-treatment
will 88 92 6233 6237 O
not 93 96 6238 6241 O
be 97 99 6242 6244 O
required 100 108 6245 6253 O
to 109 111 6254 6256 O
have 112 116 6257 6261 O
a 117 118 6262 6263 O
waiting 119 126 6264 6271 O
period 127 133 6272 6278 O
before 134 140 6279 6285 O
enrollment 141 151 6286 6296 O
onto 152 156 6297 6301 O
this 157 161 6302 6306 O
study 162 167 6307 6312 O

Positive 0 8 6313 6321 O
blood 9 14 6322 6327 B-treatment
culture 15 22 6328 6335 I-treatment
within 23 29 6336 6342 O
48 30 32 6343 6345 B-upper_bound
hours 33 38 6346 6351 I-upper_bound
of 39 41 6352 6354 O
study 42 47 6355 6360 O
enrollment 48 58 6361 6371 O

Pulse 0 5 6372 6377 B-clinical_variable
oximetry 6 14 6378 6386 I-clinical_variable
> 15 16 6387 6388 O
94 17 19 6389 6391 B-lower_bound
% 19 20 6391 6392 I-lower_bound
on 21 23 6393 6395 O
room 24 28 6396 6400 B-clinical_variable
air 29 32 6401 6404 I-clinical_variable
( 33 34 6405 6406 O
> 34 35 6406 6407 O
90 36 38 6408 6410 B-lower_bound
% 38 39 6410 6411 I-lower_bound
if 40 42 6412 6414 O
at 43 45 6415 6417 O
high 46 50 6418 6422 O
altitude 51 59 6423 6431 O
) 59 60 6431 6432 O

Random 0 6 6433 6439 O
or 7 9 6440 6442 O
fasting 10 17 6443 6450 O
glucose 18 25 6451 6458 O
within 26 32 6459 6465 O
the 33 36 6466 6469 O
upper 37 42 6470 6475 O
limits 43 49 6476 6482 O
of 50 52 6483 6485 O
normal 53 59 6486 6492 O
for 60 63 6493 6496 O
age 64 67 6497 6500 B-age

Refractory 0 10 6501 6511 O
bone 11 15 6512 6516 O
marrow 16 22 6517 6523 O
involvement 23 34 6524 6535 O
defined 35 42 6536 6543 O
as 43 45 6544 6546 O
MRD 46 49 6547 6550 B-clinical_variable
â‰¥ 50 51 6551 6552 O
0.1 52 55 6553 6556 B-lower_bound
% 55 56 6556 6557 I-lower_bound
blasts 57 63 6558 6564 O
done 64 68 6565 6569 O
at 69 71 6570 6572 O
a 72 73 6573 6574 O
COG 74 77 6575 6578 O
- 77 78 6578 6579 O
approved 78 86 6579 6587 O
MRD 87 90 6588 6591 O
testing 91 98 6592 6599 O
lab 99 102 6600 6603 O
after 103 108 6604 6609 O
most 109 113 6610 6614 O
recent 114 120 6615 6621 O
treatment 121 130 6622 6631 B-treatment
regimen 131 138 6632 6639 I-treatment
. 138 139 6639 6640 O
in 140 142 6641 6643 O
the 143 146 6644 6647 O
bone 147 151 6648 6652 O
marrow 152 158 6653 6659 O
( 159 160 6660 6661 O
M23 160 163 6661 6664 O
) 163 164 6664 6665 O
and 165 168 6666 6669 O
any 169 172 6670 6673 O
CNS 173 176 6674 6677 O
status 177 183 6678 6684 O

Rituximab 0 9 6685 6694 B-treatment
= 10 11 6695 6696 O
66 12 14 6697 6699 O
days 15 19 6700 6704 O
, 19 20 6704 6705 O
Epratuzumab 21 32 6706 6717 B-treatment
= 33 34 6718 6719 O
69 35 37 6720 6722 O
days 38 42 6723 6727 O

SGPT 0 4 6728 6732 B-clinical_variable
( 5 6 6733 6734 I-clinical_variable
ALT 6 9 6734 6737 I-clinical_variable
) 9 10 6737 6738 I-clinical_variable
and 11 14 6739 6742 I-clinical_variable
SGOT 15 19 6743 6747 I-clinical_variable
( 20 21 6748 6749 I-clinical_variable
AST 21 24 6749 6752 I-clinical_variable
) 24 25 6752 6753 I-clinical_variable
must 26 30 6754 6758 O
be 31 33 6759 6761 O
less 34 38 6762 6766 O
than 39 43 6767 6771 O
3 44 45 6772 6773 B-upper_bound
x 46 47 6774 6775 I-upper_bound
institutional 48 61 6776 6789 I-upper_bound
upper 62 67 6790 6795 I-upper_bound
limit 68 73 6796 6801 I-upper_bound
of 74 76 6802 6804 I-upper_bound
normal 77 83 6805 6811 I-upper_bound
( 84 85 6812 6813 O
Grade 85 90 6813 6818 B-upper_bound
1 91 92 6819 6820 I-upper_bound
or 93 95 6821 6823 O
less 96 100 6824 6828 O
per 101 104 6829 6832 O
CTCAE 105 110 6833 6838 O
4 111 112 6839 6840 O

Second 0 6 6841 6847 O
or 7 9 6848 6850 O
greater 10 17 6851 6858 O
relapse 18 25 6859 6866 O
B 26 27 6867 6868 O
- 27 28 6868 6869 O
cell 28 32 6869 6873 O
patients 33 41 6874 6882 O
are 42 45 6883 6886 O
eligible 46 54 6887 6895 O
at 55 57 6896 6898 O
time 58 62 6899 6903 O
of 63 65 6904 6906 O
relapse 66 73 6907 6914 O
or 74 76 6915 6917 O
with 77 81 6918 6922 O
refractory 82 92 6923 6933 B-chronic_disease
disease 93 100 6934 6941 I-chronic_disease

Serum 0 5 6942 6947 B-clinical_variable
albumin 6 13 6948 6955 I-clinical_variable
greater 14 21 6956 6963 O
than 22 26 6964 6968 O
or 27 29 6969 6971 O
equal 30 35 6972 6977 O
to 36 38 6978 6980 O
2 39 40 6981 6982 B-lower_bound
g 41 42 6983 6984 I-lower_bound
/ 42 43 6984 6985 I-lower_bound
dL 43 45 6985 6987 I-lower_bound

Shortening 0 10 6988 6998 B-clinical_variable
fraction 11 19 6999 7007 I-clinical_variable
of 20 22 7008 7010 O
â‰¥ 23 24 7011 7012 O
27 25 27 7013 7015 B-lower_bound
% 27 28 7015 7016 I-lower_bound
by 29 31 7017 7019 O
echocardiogram 32 46 7020 7034 B-clinical_variable

Stem 0 4 7035 7039 B-treatment
Cell 5 9 7040 7044 I-treatment
Infusion 10 18 7045 7053 I-treatment
: 18 19 7053 7054 O
No 20 22 7055 7057 O
evidence 23 31 7058 7066 O
of 32 34 7067 7069 O
active 35 41 7070 7076 O
graft 42 47 7077 7082 O
vs. 48 51 7083 7086 O
host 52 56 7087 7091 B-chronic_disease
disease 57 64 7092 7099 I-chronic_disease
and 65 68 7100 7103 O
at 69 71 7104 7106 O
least 72 77 7107 7112 O
84 78 80 7113 7115 B-lower_bound
days 81 85 7116 7120 I-lower_bound
must 86 90 7121 7125 O
have 91 95 7126 7130 O
elapsed 96 103 7131 7138 O
after 104 109 7139 7144 O
transplant 110 120 7145 7155 B-treatment
or 121 123 7156 7158 O
stem 124 128 7159 7163 B-treatment
cell 129 133 7164 7168 I-treatment
infusion 134 142 7169 7177 I-treatment

Total 0 5 7178 7183 O
bilirubin 6 15 7184 7193 B-clinical_variable
( 16 17 7194 7195 O
sum 17 20 7195 7198 O
of 21 23 7199 7201 O
conjugated 24 34 7202 7212 O
+ 35 36 7213 7214 O
unconjugated 37 49 7215 7227 O
) 49 50 7227 7228 O
must 51 55 7229 7233 O
be 56 58 7234 7236 O
less 59 63 7237 7241 O
than 64 68 7242 7246 O
or 69 71 7247 7249 O
equal 72 77 7250 7255 O
to 78 80 7256 7258 O
1.5 81 84 7259 7262 B-upper_bound
x 85 86 7263 7264 I-upper_bound
normal 87 93 7265 7271 I-upper_bound
per 94 97 7272 7275 I-upper_bound
institutional 98 111 7276 7289 I-upper_bound
normal 112 118 7290 7296 I-upper_bound
values 119 125 7297 7303 O
for 126 129 7304 7307 O
age 130 133 7308 7311 B-age

XRT 0 3 7312 7315 B-treatment
: 3 4 7315 7316 O
At 5 7 7317 7319 O
least 8 13 7320 7325 O
14 14 16 7326 7328 B-lower_bound
days 17 21 7329 7333 I-lower_bound
after 22 27 7334 7339 O
local 28 33 7340 7345 O
palliative 34 44 7346 7356 B-treatment
XRT 45 48 7357 7360 I-treatment
( 49 50 7361 7362 O
small 50 55 7362 7367 O
port 56 60 7368 7372 O
) 60 61 7372 7373 O

platelet 0 8 7374 7382 B-clinical_variable
count 9 14 7383 7388 I-clinical_variable
must 15 19 7389 7393 O
be 20 22 7394 7396 O
greater 23 30 7397 7404 O
than 31 35 7405 7409 O
or 36 38 7410 7412 O
equal 39 44 7413 7418 O
to 45 47 7419 7421 O
20,000 48 54 7422 7428 B-lower_bound
/ 54 55 7428 7429 I-lower_bound
mm3 55 58 7429 7432 I-lower_bound
to 59 61 7433 7435 O
initiate 62 70 7436 7444 O
therap 71 77 7445 7451 B-treatment

